CX Institutional’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
CX Institutional's RMD Position: Q3 2026 in Review
CX Institutional reduced its ResMed (RMD) stake by 1.7% in Q3 2026, selling an estimated $8.51K and leaving 2,258 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #472.
CX Institutional first reported a position in RMD in Q4 2018 and has held it in 26 quarters since. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- CX Institutional held 2,258 shares of ResMed worth $499K as of Q3 2026.
- CX Institutional sold 39 ResMed shares in Q3 2026, an estimated $8.51K.
- ResMed made up 0.01% of CX Institutional's portfolio in Q3 2026, its #472 holding.
- CX Institutional first reported a position in ResMed in Q4 2018 and has held it in 26 quarters since.
- 167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.